<p>RA Capital Management, L.P. has reported a disposal of common shares of Fulcrum Therapeutics Inc., according to a recent SEC filing. The transaction was reported by multiple beneficial owners, including Peter Kolchinsky and Rajeev M. Shah, among other reporting beneficial owners. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fulcrum Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001231919-25-000596), on December 10, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

FULC

<p>RA Capital Management, L.P. has sold common shares of Fulcrum Therapeutics Inc., as reported in a recent SEC filing. The transaction involved multiple beneficial owners, including Peter Kolchinsky and Rajeev M. Shah. The original filing can be accessed via EDGAR, the SEC's system. This AI-generated news brief is for informational purposes only and not financial advice.</p>

RA Capital Management Reports Sale of Fulcrum Therapeutics Common Shares